logo
Science Portal
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
About MSF Science Portal
About
Contact Us
Frequently Asked Questions (FAQs)
Privacy Policy
Terms of Use
Copyright © Médecins Sans Frontières
v2.1.5153.produseast1
Improving rotavirus vaccine coverage: Can newer-generation and locally produced vaccines help? | Journal Article / Commentary | MSF Science Portal
Journal Article
|Commentary

Improving rotavirus vaccine coverage: Can newer-generation and locally produced vaccines help?

Deen JL, Lopez AMZ, Kanungo S, Wang XY, Ahn DD, Tapia M, Grais RF
Download

Similar Content
Loading...
Loading...
Loading...
Abstract
There are two internationally available WHO-prequalified oral rotavirus vaccines (Rotarix and RotaTeq), two rotavirus vaccines licensed in India (Rotavac and Rotasiil), one in China (Lanzhou lamb rotavirus vaccine) and one in Vietnam (Rotavin-M1), and several candidates in development. Rotavirus vaccination has been rolled out in Latin American countries and is beginning to be deployed in sub-Saharan African countries but middle- and low-income Asian countries have lagged behind in rotavirus vaccine introduction. We provide a mini-review of the leading newer-generation rotavirus vaccines and compare them with Rotarix and RotaTeq. We discuss how the development and future availability of newer-generation rotavirus vaccines that address the programmatic needs of poorer countries may help scale-up rotavirus vaccination where it is needed.

Subject Area

vaccinationinfections, viral

Languages

English
DOI
10.1080/21645515.2017.1403705
Published Date
14 Nov 2017
PubMed ID
29135339
Journal
Human Vaccines and Immunotherapeutics
Volume | Issue | Pages
Volume 14, Issue 2
Issue Date
2017-12-21
Dimensions Badge